TELA Bio COO/CFO Transition and Cost Reduction Plan Extend Cash Runway
TELA Bio CEO Heather Getz thanked Roberto Cuca for five years of contributions as he steps down today as COO and CFO. The company outlined disciplined execution to strengthen its cost structure, including a one-time restructuring charge of about $1.5 million in Q3 2026 for severance and related employee costs, expected to extend its cash runway into 2028.